Special Issues
Biomedicines publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
Clinical Advances in Hepatocellular Carcinoma
Deadline: 16 October 2026
Unveiling the Genetic Architecture of Complex and Common Diseases
Deadline: 23 October 2026
Mechanisms of Cellular Senescence and Inflammation in Cardiovascular Disease
Deadline: 30 October 2026
Pharmacogenomics and Drug Metabolism: From Cytochrome P450 to Emerging Enzymatic Pathways
Deadline: 30 October 2026
Novel Drug Delivery Systems: Design, Evaluation and Application: 2nd Edition
Deadline: 30 October 2026
Research Progress on Antimicrobial Resistance (AMR)
Deadline: 30 October 2026
Advances in Bone Metabolism, Bone Homeostasis and Osteogenesis
Deadline: 30 October 2026
Neurotransmitter Signaling in Central Nervous System Diseases: Mechanisms, Biomarkers and Therapeutic Targets
Deadline: 30 October 2026
"Small Molecule Inhibitors" in Biomedicines
Deadline: 30 October 2026
Biological and Targeted Therapies in Rheumatic Diseases
Deadline: 30 October 2026
Gut–Brain Axis in Neuropsychiatric and Neurodegenerative Disorders
Deadline: 30 October 2026
Neurovascular Dysfunction: Mechanisms and Therapeutic Strategies
Deadline: 31 October 2026
of 56

